STOCK TITAN

Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Precision Optics (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, has scheduled its fourth quarter and fiscal year 2025 financial results conference call for September 29, 2025, at 5:00 p.m. ET.

The company will release its financial results and file its 10-K after market close on the same day. Investors can join via phone at (844) 735-3662 or (412) 317-5705, or through a live webcast. A replay will be available for seven days following the call.

Precision Optics (Nasdaq: POCI), azienda leader nel design e nella produzione di strumenti ottici avanzati per i settori medicale e difesa/aerospaziale, ha programmato la conferenza sui risultati finanziari del quarto trimestre e dell’esercizio 2025 per il 29 settembre 2025, alle 17:00 ora ET.

L’azienda pubblicherà i risultati e presenterà il 10-K dopo la chiusura del mercato nello stesso giorno. Gli investitori possono partecipare telefonicamente al numero (844) 735-3662 o (412) 317-5705, oppure tramite una trasmissione in diretta. una replica sarà disponibile per sette giorni dopo la chiamata.

Precision Optics (Nasdaq: POCI), una destacada diseñadora y fabricante de instrumentos ópticos avanzados para las industrias médica y de defensa/espacio, ha programado su conferencia de resultados financieros del cuarto trimestre y del ejercicio 2025 para el 29 de septiembre de 2025, a las 5:00 p.m. ET.

La empresa revelará sus resultados y presentará su Formulario 10-K después del cierre del mercado ese mismo día. Los inversores pueden unirse por teléfono al (844) 735-3662 o (412) 317-5705, o a través de una transmisión en vivo. Habrá una reproducción disponible durante siete días posteriores a la llamada.

Precision Optics (Nasdaq: POCI), 의료 및 방위/항공 우주 산업용 첨단 광학 기기 설계 및 제조를 선도하는 기업은 2025년 9월 29일 동부 표준시(ET) 기준 오후 5:00에 제4분기 및 2025 회계연도 실적 발표 컨퍼런스 콜을 계획했습니다.

회사는 같은 날 장 마감 후 실적을 발표하고 10-K를 제출합니다. 투자자들은 전화(844) 735-3662 또는 (412) 317-5705로 참여하거나 라이브 웹캐스트를 통해 참여할 수 있습니다. 콜 후 7일 동안 재생이 제공됩니다.

Precision Optics (Nasdaq: POCI), une société leader dans la conception et la fabrication d’instruments optiques avancés pour les secteurs médical et défense/aérospatial, a prévu sa conférence téléphonique sur les résultats financiers du quatrième trimestre et de l’exercice 2025 pour le 29 septembre 2025 à 17h00 ET.

L’entreprise publiera ses résultats et déposera son 10-K après la clôture du marché le même jour. Les investisseurs peuvent se joindre par téléphone au (844) 735-3662 ou au (412) 317-5705, ou via une diffusion en direct. Une rediffusion sera disponible pendant sept jours après l’appel.

Precision Optics (Nasdaq: POCI), ein führender Designer und Hersteller fortschrittlicher optischer Instrumente für die Medizin- sowie Verteidigungs-/Luftfahrtindustrie, hat seine Telefonkonferenz zu den Finanzergebnissen des vierten Quartals und des Geschäftsjahres 2025 für den 29. September 2025 um 17:00 Uhr ET terminiert.

Das Unternehmen wird seine Finanzergebnisse bekannt geben und am selben Tag nach Börsenschluss den 10-K einreichen. Investoren können telefonisch unter (844) 735-3662 oder (412) 317-5705 teilnehmen oder per Live-Webcast zuschalten. Eine Wiederholung steht sieben Tage nach dem Anruf zur Verfügung.

Precision Optics (Nasdaq: POCI)، وهي رائدة في تصميم وتصنيع الآلات البصرية المتقدمة للصناعات الطبية والدفاع/الفضاء، حددت مؤتمرها الهاتفي لنتائج الربع الرابع والسنة المالية 2025 ليكون في 29 سبتمبر 2025، الساعة 5:00 مساءً بتوقيت شرق الولايات المتحدة.

ستُعلن الشركة عن نتائجها وتقدم نموذج 10-K بعد الإغلاق السوقي في نفس اليوم. يمكن للمستثمرين الانضمام عبر الهاتف على الرقمين (844) 735-3662 أو (412) 317-5705، أو من خلال بث مباشر. ستكون هناك إعادة تشغيل متاحة لمدة سبعة أيام بعد المكالمة.

Precision Optics (纳斯达克股票代码: POCI),一家在医疗和防务/航空航天领域开发与制造先进光学仪器的领先设计商,已将2025财年第四季度及全年财务业绩电话会议定于 2025年9月29日,美国东部时间下午5:00举行。

公司将在同一天交易结束后发布业绩并提交年度报告(10-K)。投资者可通过电话(844)735-3662 或(412)317-5705 参与,或通过在线实时 webcast 参与。电话会议结束后七天内可回放。

Positive
  • None.
Negative
  • None.

GARDNER, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s fourth quarter and fiscal year 2025 financial results on Monday, September 29, 2025, at 5:00 p.m. ET.

The Company intends to release its financial results and to file its 10-K after the close of the market on Monday, September 29, 2025, followed by the conference call.

Conference Call Details

Date and Time: Monday, September 29, 2025, at 5:00 p.m. ET.

Call-in Information: Interested parties can access the conference call by dialing (844) 735-3662 or
(412) 317-5705.

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available at https://app.webinar.net/09EyQ6EXoDx.

Replay: A teleconference replay of the call will be available for seven days, at (877) 344-7529 or (412) 317-0088, replay access code 3770234. A webcast replay will be available at https://app.webinar.net/09EyQ6EXoDx.

About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.

About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800

Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com


FAQ

When is Precision Optics (POCI) Q4 2025 earnings call?

Precision Optics' Q4 and fiscal year 2025 earnings call is scheduled for Monday, September 29, 2025, at 5:00 p.m. ET.

How can I access Precision Optics (POCI) Q4 2025 earnings call?

You can access the call by dialing (844) 735-3662 or (412) 317-5705, or via live webcast at https://app.webinar.net/09EyQ6EXoDx.

When will Precision Optics (POCI) release its Q4 2025 financial results?

Precision Optics will release its Q4 and fiscal year 2025 financial results and file its 10-K after market close on Monday, September 29, 2025.

How long will the replay of POCI's Q4 2025 earnings call be available?

A teleconference replay will be available for seven days using access code 3770234, and a webcast replay will also be available online.
Precision Optics

NASDAQ:POCI

POCI Rankings

POCI Latest News

POCI Latest SEC Filings

POCI Stock Data

33.56M
6.25M
18.29%
34.31%
0.71%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
GARDNER